Showing 591 - 600 of 1108 results

Showing Results for: “diabetes exercise”

Eureka Man Commemorates His 50th ‘Diaversary’ by Achieving Special Challenge to Support the American Diabetes Association®

Long-time Eureka resident Brad Albee began 2020 looking for a way to commemorate his 50th year of thriving with diabetes since his early childhood diagnosis with type 1 diabetes in 1970. It was then that he selected the American Diabetes Association’s (ADA) Wine Country Tour de Cure to celebrate this incredible accomplishment. Brad knew he wanted to celebrate his Silver ‘Diaversary’ (i.e., anniversary of being diagnosed with diabetes) on a bike, specifically on a recumbent bike, which is Brad’s preferred way of getting the outdoors exercise he seeks as a vital component of his regimen to stay

Ayudando a los hispanohablantes a vincular la diabetes tipo 2 con las enfermedades cardíacas y los derrames cerebrales

La American Heart Association y la American Diabetes Association amplían la colaboración de la iniciativa Know Diabetes by Heart™ con la campaña en español Una nueva campaña educativa de la American Heart Association y la American Diabetes Association busca aumentar el conocimiento y la acción entre las personas con diabetes tipo 2 cuyo idioma principal es el español con el fin de enfatizar el vínculo entre la diabetes de tipo 2 y las enfermedades cardíacas y los derrames cerebrales. El anuncio se realiza durante el mes de la Herencia Hispana (del 15 de septiembre al 15 de octubre). La campaña

Delayed Onset of Type 2 Diabetes by Six Years or More Significantly Reduces Risk of Cardiovascular Disease and Microvascular Disease

People with impaired glucose tolerance (IGT) may significantly lower their risk of cardiovascular disease (CVD) and microvascular disease by delaying the onset of type 2 diabetes (T2D) by six years or more, or by returning to a normal level of glucose tolerance altogether, according to the study, “Early Progression to Diabetes or Regression to Normal Glucose Tolerance Among People with Impaired Glucose Tolerance Affects Long-Term Outcomes: Thirty-Year Follow-Up of Da Qing Diabetes Prevention Study,” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at

Stephen O’Rahilly, MD, Named American Diabetes Association’s® 2019 Banting Medal Recipient for Scientific Achievement

The American Diabetes Association® (ADA) will present the 2019 Banting Medal for Scientific Achievement, the ADA’s highest honor, to Stephen O’Rahilly, MD. The Banting Medal recognizes significant, long-term contributions to the understanding, treatment or prevention of diabetes. Dr. O’Rahilly will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco, and will deliver his Banting Medal Lecture, titled “ Treasure Your Exceptions—Studying Human Extreme Phenotypes to Illuminate Metabolic Health and Disease ,”

Liraglutide and Insulin More Effective in Maintaining Average Blood Glucose Levels Than Other Common Diabetes Drugs

Head-to-head comparison of glucose-lowering medications helps inform individualized treatment strategies Today, investigators sponsored by the National Institutes of Health announced findings from the largest and longest study comparing the effectiveness of common medications to treat type 2 diabetes. Results of the GRADE study were presented at the virtual 81st Scientific Sessions of the American Diabetes Association (ADA). Controlling blood glucose levels over time is a major challenge for people with type 2 diabetes, a condition that disproportionally impacts Black and Hispanic people, who

American Diabetes Association® Secures Insulin Price Reductions for Seniors Through New CMS Senior Savings Model

New Program Will Cap Medicare Monthly Co-Pays at $35 Today, the American Diabetes Association (ADA) joined the Centers for Medicare and Medicaid Services (CMS) for a White House event to announce the Part D Senior Savings Model, which will limit the cost of insulin for participating seniors to a maximum of $35 for a 30-day supply. “Together, we are helping 3.3 million seniors access insulin more affordably through significant caps on out-of-pocket co-pays,” said Tracey D. Brown, CEO of the American Diabetes Association. “The American Diabetes Association – the nation’s leading organization for

The American Diabetes Association® Celebrates Milestone of Novo Nordisk's Support for the 5K@ADA: 15 Years Running

The American Diabetes Association (ADA) and Novo Nordisk, one of the world's leading companies in diabetes management and long-time supporter of the ADA, announce the transition of their 15-year signature 5K@ADA Run/Walk event to a virtual challenge. The 5K@ADA has been an official event during the Scientific Sessions for 15 years and has brought together over 13,400 participants. Through the continued support of Novo Nordisk, the 5K@ADA Virtual Challenge is free of charge to all participants. Everyone is encouraged to sign up , lace up and head out the door, right from their home over the

Outstanding Leaders in Specialized Areas of Diabetes Research, Prevention and Treatment to be Recognized at ADA’s 80th Scientific Sessions

The American Diabetes Association (ADA) announces this year’s Professional Interest Group and Women’s Interprofessional Network Award recipients The American Diabetes Association® (ADA) is proud to announce the recipients of the 2020 Professional Interest Group and Women’s Interprofessional Network Awards. These awards, presented by various membership groups, recognize academics, health care providers and educators who have contributed to advances in specialized areas of diabetes care and research. Each recipient has shown outstanding commitment to achieving the vision of the ADA: life free of

More Peril than Promise in President Trump’s Proposed Budget Which Would Endanger the Lives of Millions with Diabetes

Following the release of President Trump’s budget proposal for Fiscal Year 2021, Tracey D. Brown, Chief Executive Officer of the American Diabetes Association (ADA), issued the following statement: “Yesterday, the White House announced its FY2021 budget. While we were encouraged to see that the President recommended extending the highly successful Special Diabetes Program (SDP), we ask Congress to go further and provide a long-term renewal for SDP. In addition, far too many other public health and biomedical research programs would be subject to severe cuts under the President’s proposal